NCT06734585 2025-09-12
Using Gilteritinib to Keep People With Acute Myeloid Leukemia Cancer-free After a Stem Cell Transplant
Astellas Pharma Inc
Completed
Clinical Trials
4 trialsNCT04691648 2025-05-31
A Study to Assess the Safety of Xospata in Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-Like Tyrosine Kinase 3 (FLT3) Mutation
Astellas Pharma Inc
Completed
NCT05791890 2023-03-30
GilteRInf
University of Rome Tor Vergata
Unknown
NCT05312112 2023-03-02
Real World Outcomes Using Novel Agents for AML in the UK
Guy's and St Thomas' NHS Foundation Trust
Unknown